EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | +11.7% | 2,772 | +48.6% | 0.00% | – |
| Q1 2022 | $77,000 | -8.3% | 1,866 | -3.6% | 0.00% | -100.0% |
| Q4 2021 | $84,000 | +25.4% | 1,936 | +45.1% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -27.2% | 1,334 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $92,000 | -39.5% | 1,466 | -10.4% | 0.00% | -50.0% |
| Q1 2021 | $152,000 | -55.9% | 1,637 | -57.5% | 0.00% | -60.0% |
| Q4 2020 | $345,000 | +807.9% | 3,855 | +985.9% | 0.01% | +400.0% |
| Q3 2020 | $38,000 | -83.2% | 355 | -87.2% | 0.00% | -75.0% |
| Q2 2020 | $226,000 | +1954.5% | 2,765 | +1162.6% | 0.00% | – |
| Q3 2019 | $11,000 | -26.7% | 219 | -28.4% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | +275.0% | 306 | +302.6% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 76 | +81.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |